Decreased level of TREM like Transcript 1 (TLT‐1) is associated with prematurity and promotes the in‐utero inflammatory response to maternal lipopolysaccharide (LPS) exposure

Abstract

AbstractProblemThe occurrence of preterm birth is associated with multiple factors including bleeding, infection and inflammation. Platelets are mediators of hemostasis and can modulate inflammation through interactions with leukocytes. TREM like Transcript 1 (TLT‐1) is a type 1 single Ig domain receptor on activated platelets. In adults, it plays a protective role by dampening the inflammatory response and facilitating platelet aggregation at sites of vascular injury. TLT‐1 is expressed in human placenta and found in cord blood. We thus hypothesized that TLT‐1 deficiency is associated with prematurity and fetal inflammation.Method of studyTo test this hypothesis, we examined cord blood levels of soluble TLT‐1 (sTLT) in premature and term infants and compared the inflammatory response in C57BL/6 (WT) and TLT‐1−/− (treml1−/−, KO) mice given intraperitoneal LPS mid‐gestationResultsThe preterm infant cord blood level of sTLT was significantly lower than that found at term. On exposure to LPS, histology of KO (as compared to WT) placenta and decidua showed increased hemorrhage, and KO decidual RNA expression of IL‐10 was significantly lower. KO fetal interface tissues (placenta, membranes, amniotic fluid) over time showed increased expression of inflammatory cytokines such as IL‐6, IFN‐γ, and TNF, but not MCP‐1. However, fetal organs showed similar levels.ConclusionThere is a potential association between insufficient TLT‐1 expression and increased fetal inflammatory responses in the setting of prematurity. The data support further study of TLT‐1 in the mechanistic link between bleeding, inflammation and preterm birth, and perhaps as a biomarker in human pregnancy.